Affimed N.V. (NASDAQ:AFMD) Q3 2023 Results Earnings Conference Call November 14, 2023 8:30 AM ET

Company Participants

Alexander Fudukidis - Director and Head of Investor Relations

Adi Hoess - Chief Executive Officer

Andreas Harstrick - Chief Medical Officer

Angus Smith - Chief Financial Officer

Wolfgang Fischer - Chief Operating Officer

Conference Call Participants

Srikripa Devarakonda - Truist Securities

Li Watsek - Cantor Fitzgerald

Daina Graybosch - Leerink Partners

Yanan Zhu - Wells Fargo

Bradley Canino - Stifel Financial

Yale Jen - Laidlaw & Company

Sean Lee - H.C. Wainwright & Co.

Operator

Good day, everyone, and welcome to Affimed N.V. Third Quarter 2023 Earnings and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there'll be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.

Alexander Fudukidis

Thank you, Norma. And thank you all for joining us today for our third quarter 2023 update call. Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today, which can be found on the Investor Relations section of our website. The presentation is also on the website.

On the call today, we have the members of our management team, including our Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; and Angus Smith, our Chief Financial Officer. The team will be available for Q&A after the prepared remarks.

Before we start, I would like to remind everyone that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. These forward-looking statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied in these statements due to various factors including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC, and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC.